Posters
Late-Breaking Research Posters
October 22, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Late-Breaking Research Posters
Note: Continuing education credits are not being offered for this session.
Learning Pathway(s)
- Other
Posters
Nine Million Candidates, Four in Five Unaware: The CKD Detection Gap Limiting Kidney-Protective GLP-1 Receptor Agonist Therapy in US Adults with Type 2 Diabetes
Clinical Decision Support Triggers to Improve CKD Screening and Detection in Primary Care: The ALMA-CKD Pragmatic Cluster Randomized Trial
Effect of a Video Decision Aid and Patient-Created Video Declarations on Advance Care Planning Documentation Among Older Adults with Advanced CKD
Genetically-Anchored Kidney Aging and Risk of Incident CKD
Occupational Heat, Air Pollution, Physiological Heat Strain, and Kidney and Inflammatory Biomarkers Among Guatemalan Sugarcane Workers
Redefining the Natural History and Management of Sickle Cell Kidney Disease (SCKD): Integration of Systematic Evidence with the American Society of Hematology Research Collaborative (ASH RC) Data Hub
Targeted Autosomal Dominant Tubulointerstitial Kidney Disease Gene Evaluation of Early-Onset CKD of Unknown Etiology in Mexico
Strong Independent Association of CKD Progression with Cardiovascular (CV) Events in Patients with Moderate-to-Advanced CKD: Results of the PEAK-CKD Study
Effect of Aprocitentan on Kidney Function in Patients with Hypertension, with or Without CKD
Electrolyte, Water, and Blood Pressure Homeostasis with Balcinrenone and Dapagliflozin in Patients with CKD: The DapaBalci-Leap Trial
Effects of Retatrutide on Kidney Parameters in Participants with Obesity or Overweight and CKD
Effects of Finerenone on Kidney and Cardiovascular Outcomes in Patients with CKD and Type 1 Diabetes: An Analysis from FINE-ONE and FIDELITY
Finerenone in Patients with FSGS: A FIND-CKD Analysis
TREASURE-CKD: Tirzepatide Mechanism of Action Study on Kidney Structure and Function
Kidney Outcomes Associated with Tirzepatide vs. GLP-1 Receptor Agonist Use in Patients with Type 2 Diabetes and CKD
The Veterans Affairs Pentoxifylline in Diabetic Kidney Disease (VA PTXRx) Study: Baseline Characteristics
Pentoxifylline for Diabetic Kidney Disease: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis
Activity of the Novel Anti-Soluble Urokinase Plasminogen Activator Receptor (suPAR) Monoclonal Antibody WAL0921 in People with Diabetic Kidney Disease
Vertical Sleeve Gastrectomy Is Associated with Improved Cardiac and Kidney Phenotypes in Youth with Obesity and Type 2 Diabetes
Dietary Potassium Liberalization with Fruits and Vegetables in People with CKD: A Randomized Crossover Clinical Trial
Reducing Dietary Acid with Fruits and Vegetables vs. Oral Alkali in People with CKD (ReDACKD): A Randomized Controlled Feasibility Trial
Extended-Release Calcifediol Improves Skeletal Remodeling Balance as Assessed by a CKD-Adapted Bone Balance Index
Telitacicept in Patients with Refractory IgA Nephropathy: A Randomized, Open-Label Clinical Trial
Sarcopenic Obesity and Gut-Derived Glycylvaline in Relation to Myocardial Fibrosis in Patients with ESRD on Maintenance Dialysis
Long-Term Efficacy and Safety of Iptacopan in Patients with IgA Nephropathy
Finerenone in Patients with IgA Nephropathy: A FIND-CKD Analysis
Efficacy and Safety of B-Cell-Directed Therapies in IgA Nephropathy: A Collaborative Meta-Analysis
A Randomized, Placebo-Controlled Phase 2 Trial of a Long-Acting, C3-Targeting siRNA in IgA Nephropathy
Telitacicept for IgA Nephropathy: Final Two-Year Results of the Phase 3 TELIGAN Trial
The ORIGIN 3 Trial: Atacicept in IgA Nephropathy
Sibeprenlimab in IgA Nephropathy: 24 Months of Data from the Phase 3 VISIONARY Trial
Interim Phase 2 Results of SGB-9768, a Liver-Targeted GalNAc-siRNA-Targeting Complement C3, in IgA Nephropathy, C3 Glomerulopathy, and Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Relationship Between Proteinuria Reduction and Preservation of GFR in Patients with IgA Nephropathy
First-in-Human Clinical Trial of CPV-104, a Recombinant Version of Human Complement Factor H: Safety, Tolerability, and Pharmacokinetics for C3 Glomerulopathy
Efficacy and Safety of Eculizumab in Patients with Anti-Glomerular Basement Membrane Disease: An Investigator-Initiated, Open-Label, Phase 2 Clinical Trial
Molecular Profiling of Antinephrin Autoantibodies Reveals IgG3/IgG4 Predominance and Shared Immunodominant Epitopes in Recurrent FSGS
Maintenance Rituximab Reduces Relapse in Phospholipase A2 Receptor (PLA2R)-Related Membranous Nephropathy: A Retrospective Cohort Study
A Phase 2 Open-Label Trial Evaluating the Efficacy and Safety of Daratumumab (Dara) in Treatment of Patients with Active Lupus Nephritis (LN)
Cross-Ancestry Transferability of a Tubulointerstitial Molecular Classification to an Indigenous West African Cohort with Proteinuric Disease
GLP-1 Receptor Agonist Therapy Within Three Years After Kidney Transplant Is Associated with Improved Graft and Patient Survival
Early Experience of Sibeprenlimab in Kidney Transplant Recipients with Disease Recurrence and Antibody Mediated Rejection
Biopsy-Guided Management Improves Renal Outcomes After Liver Transplantation: A Matched Cohort Study
The ODYSSEE-Kidney Health Trial for Home Kidney Replacement Therapy (KRT)
Use of the CloudCath Remote Monitoring System Is Associated with Retention on Peritoneal Dialysis
Niaoduqing Granules Improve Constipation in Patients with Peritoneal Dialysis: A Multicenter Prospective Controlled Study
ACTIVE-PD: Supervised Physical Exercise Improves Maximal Oxygen Consumption (VO2max) and Physical Function in Patients on Automated Peritoneal Dialysis
MotiVational Strategies to Empower African Americans to Improve Dialysis Adherence (MoVE Trial): A Randomized Controlled Trial
GLP-1 Receptor Agonist Initiation and Mortality in Patients on Maintenance Hemodialysis: A Target Trial Emulation
Efficacy and Safety of Gosicalcetide vs. Cinacalcet in Patients with Secondary Hyperparathyroidism Receiving Hemodialysis: Results from a Phase 3 Randomized Clinical Trial
Long-Term Safety of Gosicalcetide in Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
Sodium Thiosulfate Attenuates Coronary Artery Calcification and Uremic Pruritus: A Randomized Crossover Trial
Effect of Intradialytic Exercise on Serum Fibroblast Growth Factor 23 (FGF-23) Levels and Left Ventricular Structure and Function in Patients on Hemodialysis: A Randomized Controlled Trial Pilot Study
Spectrum and Burden of Arrhythmias in Patients with ESKD on Maintenance Hemodialysis: A 48-Hour Holter Monitoring Study
Outcomes for Veterans in Veterans Affairs (VA) and VA Community Care Dialysis Settings Favor VA and Were Not Impacted by the COVID-19 Pandemic
Flow Surveillance or Clinical Monitoring to Guide Vascular Access Maintenance: A Double-Blind Randomized Controlled Trial
Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation (pAVF) in a 1,000-Patient Cohort: Maturation, Patency, and Predictors of Abandonment
Proton Pump Inhibitor Use Is Associated with Improved Arteriovenous Fistula Patency in Patients with ESKD: A Retrospective Cohort Study with Experimental Support
Real-World Effectiveness of Taurolidine/Heparin Catheter Lock Solution in Patients on Hemodialysis with Central Venous Catheters
A Decellularized Biological Vascular Graft for Hemodialysis Access: 18-Month First-in-Human Clinical Outcomes of LineMatrix
Clinical Evaluation of a Novel Polyethersulfone Hemodiafiltration Filter: A Multicenter Randomized Crossover Noninferiority Trial
Multihospital Electronic Decision Support for Drug-Associated AKI (MEnD-AKI): A Prospective Cluster-Randomized Clinical Trial
Early Medication-Specific Recommendations for AKI from the KAT-AKI Trial
Improved Outcomes in Pediatric Sepsis-Associated (SA) AKI: Comparison of the Selective Cytopheretic Device for Pediatrics (SCD-PED) Surveillance Registry (SAVE) with a Historical Cohort
eGFR Difference and Platinum-Associated Adverse Events in Patients with Cancer
Reducing Fluid Overload in Cardiorenal Syndrome by Enhancing Insensible Fluid Loss: The REFORM-HF Trial
Can Inferior Vena Cava Diameter and Collapsibility Index Predict Renal Response to Diuretic Therapy in Heart Failure?
Izicopan, a Second-Generation Oral C5a Receptor 1 (C5aR1) Antagonist, Demonstrates Promising Therapeutic Potential in Kidney Disease Models
First-in-Human Study of SK-09, a Novel Transient Receptor Potential iChannel-5 Inhibitor: Safety, Tolerability, and Pharmacokinetics in Healthy Participants
A Wearable, Real-Time Creatinine Monitor Supports the Early Detection and Quantification of Changing Renal Function
Digital Cognitive Behavioral Therapy for Hyperkalemia in Patients on Maintenance Hemodialysis: A Prospective, Single-Center, Randomized Controlled Trial